european association for the study of diabetes

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

1.038 documents for european association for the study of diabetes

- King Pharmaceuticals Reports DREAM Data on Ramipril; Results Presented at the European Association for the Study Of Diabetes (EASD) and Published in the New England Journal of Medicine.
BRISTOL, Tenn. -- King Pharmaceuticals, Inc. (NYSE:KG) today reported that the results of the Diabetes Reduction Assessment with Ramipril and Rosiglit...
- Business Wire
- September 15, 2006
- OSI Pharmaceuticals Presents Research Data on its Dipeptidyl Peptidase IV Inhibitor, PSN9301, at the 41st Annual Meeting of the European Association for the Study of Diabetes.
MELVILLE, N.Y. -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that (OSI) Prosidion, its UK subsidiary focused on the discovery and develo...
- Business Wire
- September 15, 2005
- Study Results Show Diachrome(R) Improves Poorly-Controlled Blood Sugar Levels for People on Antidiabetic Prescription Medications; Findings Presented at 41st Annual Meeting of the European Association for the Study of Diabetes.
ATHENS, Greece -- Nutrition 21 (NASDAQ: NXXI): A sub-set analysis from a Diachrome(R) XLHealth clinical trial demonstrates that adding daily supplem...
- Business Wire
- September 13, 2005

- New Global Guidelines for Type 2 Diabetes Are Achievable; Guidelines Reaffirm Ace/Aace's Tighter Standard for A1c Target
JACKSONVILLE, Fla., Sept. 15 /U.S. Newswire/ -- The American College of Endocrinology (ACE) and the American Association of Clinical Endocrinologists (AACE) applaud the International Diabetes Federation (IDF) for formally endorsing an A1C standard of below 6.5 percent, at the European Association for the Study of Diabetes (EASD) meeting Tuesday. ACE/AACE is proud to be the first major medical organization to officially adopt a goal of A1C less than 6.5 percent at our diabetes treatment consensus conference in 2001 followed by an implementation conference in 2005. ACE and AACE encourage patients not only in the United States, but throughout the world, to embrace the following recommendations for glucose control:
- U.S. Newswire
- September 15, 2005
- New Desks to Keep You On Your Toes
New office furniture combats the negative effects of sitting by allowing workers to stay on their feet and even to walk at their desks. The health studies that conclude that people should sit less and get up and move around more, have always struck me as fitting into the "well, duh" category.

... and in Diabetologia, a journal of the European Association for the Study of Diabetes. Suppose you...
- International Herald Tribune
- December 02, 2012
- Byetta(R) Provided Greater Glycemic Durability and Overall Glycemic Control Than Amaryl(R) in Patients with Type 2 Diabetes
New Clinical Data Presented at 2012 ADA/The Lancet Symposium also Showed Patients Treated with BYETTA Experienced Reductions in Body Weight and Fewer Hypoglycemic Events Media contact:

... announced new clinical data from the European Exenatide (EUREXA) study that showed treatment wit... Sessions of the American Diabetes Association in Philadelphia and will be published in the diabe...
- Business Wire
- June 09, 2012
- Doctors Took Money, Wrote Treatment Guidelines
MILWAUKEE - Doctors with financial ties to drug companies have heavily influenced treatment guidelines that recommend the most lucrative drugs in American medicine, an analysis by the Milwaukee Journal Sentinel and MedPage Today has found. The guidelines affect how doctors across the country treat patients for everything from diabetes to asthma, chronic pain, depression and high cholesterol.

Issued by leading medical associations and government institutions, treatment guidelines ... American Diabetes Association and the European Association for the Study of Diabetes issued recom...
- Sunday Gazette-Mail
- December 31, 2012
- Investigational Compound Dapagliflozin Sustained Glycemic Control and Weight Reduction in Study of Type 2 Diabetes Patients Inadequately Controlled with Metformin.
... today at the 71st American Diabetes Association Scientific Sessions. In addition to sustained redu... the study were presented during the 45th European Association for the Study of Diabetes (EASD) Annua...
- Business Wire
- June 25, 2011
- Gi Dynamics Announces Full-Year 2011 Financial Results
Company to Hold Conference Call to Discuss Full-Year Results: Thursday, March 1, 2012 at 5 p.m. U.S. EST/Friday, March 2, 2012 at 9 a.m. AEDT

...-surgical approaches for treating type 2 diabetes and obesity, is pleased to provide its financial r... including the Annual Meeting of the European Association for the Study of Diabetes, the World C...
- Business Wire
- February 29, 2012
- Pooled Analysis Showed Onglyza(R) (Saxagliptin) Provided Improvements in Key Measures of Blood Sugar Control in Adults with Type 2 Diabetes at High Risk for Cv Disease
Media: Bristol-Myers Squibb

... statement by the American Diabetes Association and the European Association for the Study of Diab...
- Business Wire
- July 31, 2012